17 min

Pierre Wijdenes Heart Investors

    • Investissement

Pierre is the founder of Neurara. Neuraura’s mission is to unlock safe and effective treatments for brain-related disorders. Neurological, psychiatric and sensory conditions are a global epidemic with a burden on society that is greater than cancer and cardiac conditions combined.  Current treatment options are severely limited due to a legacy of stigma, our poor understanding of the brain and practical challenges in targeting drugs, such as the blood-brain barrier. For some conditions, such as epilepsy, surgical intervention is proven to be one the medically proven best options available today.  Neuromodulation, or the electrical stimulation of specific neurons, has been shown to be effective at the research level to treat a broad range of conditions including Alzheimer’s, addiction, depression and chronic pain. Neuraura will unlock these treatment options by using its proprietary sensing technology to understand the electrical workings of the brain for personalized and adaptive brain care.

Pierre is the founder of Neurara. Neuraura’s mission is to unlock safe and effective treatments for brain-related disorders. Neurological, psychiatric and sensory conditions are a global epidemic with a burden on society that is greater than cancer and cardiac conditions combined.  Current treatment options are severely limited due to a legacy of stigma, our poor understanding of the brain and practical challenges in targeting drugs, such as the blood-brain barrier. For some conditions, such as epilepsy, surgical intervention is proven to be one the medically proven best options available today.  Neuromodulation, or the electrical stimulation of specific neurons, has been shown to be effective at the research level to treat a broad range of conditions including Alzheimer’s, addiction, depression and chronic pain. Neuraura will unlock these treatment options by using its proprietary sensing technology to understand the electrical workings of the brain for personalized and adaptive brain care.

17 min